198 related articles for article (PubMed ID: 19596931)
1. Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer.
Lindström AK; Tot T; Stendahl U; Syrjänen S; Syrjänen K; Hellberg D
Anticancer Res; 2009 Jul; 29(7):2577-8. PubMed ID: 19596931
[TBL] [Abstract][Full Text] [Related]
2. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
3. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
4. Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions.
Lindström AK; Stendahl U; Tot T; Lidström BM; Hellberg D
Anticancer Res; 2007; 27(3B):1609-15. PubMed ID: 17595784
[TBL] [Abstract][Full Text] [Related]
5. Differences in expression of tumor markers between pre- and postmenopausal women with invasive cervical cancer.
Hellberg D; Tot T; Stendahl U
Anticancer Res; 2008; 28(3B):1793-5. PubMed ID: 18630462
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.
Noriyuki M; Sumi T; Zhi X; Misugi F; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Oncol; 2007 Sep; 31(3):531-6. PubMed ID: 17671679
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas.
Baltazar F; Filho AL; Pinheiro C; Moreira MA; Queiroz GS; Oton GJ; Júnior AF; Ribeiro LF; Schmitt FC
Int J Gynecol Pathol; 2007 Jul; 26(3):235-41. PubMed ID: 17581404
[TBL] [Abstract][Full Text] [Related]
8. Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker.
Masoudi H; Van Niekerk DJ; Gilks CB; Cheang M; Bilek K; Fischer U; Ehlen T; Miller D; Horn LC
Histopathology; 2006 Nov; 49(5):542-5. PubMed ID: 17064304
[No Abstract] [Full Text] [Related]
9. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix].
Gasparian NA; Pozharisskiĭ KM; Zharinov GM; Vinokurov VL; Kuznetsova ME; Neklasova NIu
Vopr Onkol; 2007; 53(4):439-44. PubMed ID: 17969407
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor receptor kinase inser domain containing receptor in human cervical carcinoma].
Di H; Xu F; Wang D
Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):670-2. PubMed ID: 11218896
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor (VDR) expression is not a prognostic factor in cervical cancer.
Friedrich M; Meyberg R; Axt-Fliedner R; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrath J
Anticancer Res; 2002; 22(1A):299-304. PubMed ID: 12017307
[TBL] [Abstract][Full Text] [Related]
12. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
13. Tumor marker score for prognostication of early-stage squamous cell cervical cancer.
Hellberg D; Tot T
Anticancer Res; 2014 Feb; 34(2):887-92. PubMed ID: 24511027
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
[TBL] [Abstract][Full Text] [Related]
15. Expression of HIPK2 in cervical cancer: correlation with clinicopathology and prognosis.
Al-Beiti MA; Lu X
Aust N Z J Obstet Gynaecol; 2008 Jun; 48(3):329-36. PubMed ID: 18532967
[TBL] [Abstract][Full Text] [Related]
16. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
17. Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma.
Rawnaq T; Kleinhans H; Uto M; Schurr PG; Reichelt U; Cataldegirmen G; Gawad KA; Yekebas EF; Schachner M; Izbicki JR; Kaifi JT
Anticancer Res; 2009 Apr; 29(4):1195-9. PubMed ID: 19414364
[TBL] [Abstract][Full Text] [Related]
18. [The comparison of radiosensitivity between uterine cervical squamous carcinoma and adenocarcinoma].
Zhang M; Cai S; Shi D
Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):611-3. PubMed ID: 10806688
[TBL] [Abstract][Full Text] [Related]
19. [Some kinetic characteristics of cervical cancer].
Zharinov GM; Pozharisskiĭ KM; Vinokurov VL; Neklasova NIu; Mironovskaia NV; Kuznetsova ME; Tarkova AB
Vopr Onkol; 2009; 55(2):196-200. PubMed ID: 19514375
[TBL] [Abstract][Full Text] [Related]
20. Associations between ten biological tumor markers in squamous cell cervical cancer and serum estradiol, serum progesterone and smoking.
Lindström AK; Stendahl U; Tot T; Hellberg D
Anticancer Res; 2007; 27(3B):1401-6. PubMed ID: 17595754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
